Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Nima_Farzan
|
| gptkbp:focus |
precision oncology
|
| gptkbp:foundedYear |
2018
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kinnate Biopharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:products |
small molecule kinase inhibitors
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:KNTE
|
| gptkbp:therapeuticArea |
gptkb:cancer
|
| gptkbp:website |
https://kinnate.com/
|
| gptkbp:bfsParent |
gptkb:F-Prime_Capital_Partners
|
| gptkbp:bfsLayer |
6
|